Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin γl Fc or CH3 region

被引:61
作者
Alt, M [1 ]
Müller, R [1 ]
Kontermann, RE [1 ]
机构
[1] Univ Marburg, Inst Mol Biol & Tumorforsch, D-35033 Marburg, Germany
关键词
single-chain diabody; bispecific antibody; immunoglobulin constant domain; dimerization; functional affinity;
D O I
10.1016/S0014-5793(99)00782-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although bispecific IgG molecules have been successfully applied for antibody-mediated immunotherapy of tumours, applicability is hampered by the difficulties associated with their generation. In the present study, me have used a bispecific single-chain diabody (scDb) directed against carcinoembryonic antigen and Escherichia coli beta-galactosidase as a model to generate bispecific IgG-like antibody molecules. We show that the fusion of this single-chain diabody to the Fc (scDb-Fc) or CH3 (scDb-CH3) region of the human immunoglobulin gamma 1 chain results in the expression of dimeric fusion proteins exhibiting four functional antigen binding sites with increased functional affinity, This strategy represents a new and convenient way to generate IgG-like multivalent and bispecific molecules that are efficiently secreted from mammalian cells. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 32 条
  • [1] ADAMS GP, 1993, CANCER RES, V53, P4026
  • [2] BOLHUIS RLH, 1992, INT J CANCER, P78
  • [3] A TNF receptor-antagonistic scFv, which is not secreted in mammalian cells, is expressed as a soluble mono-and bivalent scFv derivative in insect cells
    Brocks, B
    HansJorgen, RB
    Klein, M
    Gerlach, E
    Dubel, S
    Little, M
    Pfizenmaier, K
    Moosmayer, D
    [J]. IMMUNOTECHNOLOGY, 1997, 3 (03): : 173 - 184
  • [4] BRUSSELBACH S, 1999, IN PRESS TUMOR TARGE
  • [5] Induction of multiple anti-c-erB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment
    Clark, JI
    Alpaugh, RK
    vonMehren, M
    Schultz, J
    Gralow, JR
    Cheever, MA
    Ring, DB
    Weiner, LM
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (05) : 265 - 272
  • [6] Design and production of novel tetravalent bispecific antibodies
    Coloma, MJ
    Morrison, SL
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (02) : 159 - 163
  • [7] Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes
    Connelly, RJ
    Hayden, MS
    Scholler, JK
    Tsu, TT
    Dupont, B
    Ledbetter, JA
    Kanner, SB
    [J]. INTERNATIONAL IMMUNOLOGY, 1998, 10 (12) : 1863 - 1872
  • [8] De Gast G C, 1995, J Hematother, V4, P433, DOI 10.1089/scd.1.1995.4.433
  • [9] BIFUNCTIONAL AND MULTIMERIC COMPLEXES OF STREPTAVIDIN FUSED TO SINGLE-CHAIN ANTIBODIES (SCFV)
    DUBEL, S
    BREITLING, F
    KONTERMANN, R
    SCHMIDT, T
    SKERRA, A
    LITTLE, M
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 178 (02) : 201 - 209
  • [10] Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody
    Hartmann, F
    Renner, C
    Jung, W
    Deisting, C
    Juwana, M
    Eichentopf, B
    Kloft, M
    Pfreundschuh, M
    [J]. BLOOD, 1997, 89 (06) : 2042 - 2047